Patients Ask: What is Mixed Cortical and Subcortical Vascular Dementia?

October 19, 2021Henry Peck

Vascular dementia is the second most common form of dementia following Alzheimer’s disease. Although vascular dementia is recognized as common, experts believe it remains relatively underdiagnosed. In general, vascular dementia is caused by conditions that reduce blood flow to the brain, such as stroke, brain hemorrhages, or chronically damaged or narrowed blood vessels in the brain or at any location in the body. Insufficient blood flow can cause damage to brain cells, eventually killing them. 

After receiving a vascular dementia diagnosis, many individuals are told that it is similar to Alzheimer’s disease. While those diagnosed with mixed cortical or subcortical vascular dementia may experience a handful of symptoms that are comparable to those found in Alzheimer’s disease, there are both clinical and pathological differences. This confusion leads individuals to wonder, “What is mixed cortical and subcortical vascular dementia?” 

Below, we detail the key distinctions between mixed cortical and subcortical vascular dementia, other causes of vascular dementia, treatments, and how to understand cognitive and functional changes occurring in vascular dementia patients.

Mixed Cortical and Subcortical Vascular Dementia

Mixed cortical and subcortical vascular dementia can be differentiated by the location of damage, and there are clinical and pathological differences as well. 

Mixed Cortical Vascular Dementia

Cortical dementia develops as a result of disorders that affect the cerebral cortex, the outermost layer of the brain. Cortical dementia typically yields a dementia signature consistent with symptoms of Alzheimer’s disease, meaning symptoms primarily involve a decline in cognitive abilities, such as memory. Mixed cortical vascular dementia is the combination of multiple dementias, including vascular dementia, that expresses the cortical dementia signature in addition to that of vascular dementia. 

In the most common form, the beta-amyloid plaques and neurofibrillary tangles associated with Alzheimer’s disease are present in addition to blood vessel changes associated with vascular dementia. According to the Alzheimer’s Society, this form of mixed dementia accounts for at least 10% of dementia diagnoses. Symptoms of mixed cortical vascular dementia may include those of Alzheimer’s, those of vascular dementia, or a combination of the two.

Subcortical Vascular Dementia

Subcortical vascular dementia, also known as Binswanger’s disease, is caused by diseases of the small blood vessels that lie in the subcortex deep within the brain. The vessel walls become thick and narrow, resulting in reduced blood flow. 

Due to the location of the damage, symptoms associated with subcortical vascular dementia are predominantly functional impairments similar to those of Parkinson’s disease. While some cognitive impairments may be present, symptoms primarily involve challenges with function and movement, such as psychomotor slowness, poor balance, unsteady gait, and changes in speech, among others.

Other Causes of Vascular Dementia

There are several other causes of vascular dementia, including post-stroke dementia and single-infarct and multi-infarct dementia. The primary differentiation between vascular dementias lies in the causes of brain damage as well as the portion of the brain that is impacted.

Post-Stroke Dementia

A major stroke occurs when blood supply to a portion of the brain is suddenly and permanently cut off, providing insufficient blood flow to the brain. As a result, the brain does not receive enough oxygen, causing brain tissue to die. Depending on the severity of stroke and location of damage, the degree of vascular dementia symptoms can vary widely and may also include functional impairments in addition to cognitive impairments. Not all individuals who have had a stroke will develop vascular dementia; however, 20% of people do develop post-stroke dementia.

Single-Infarct and Multi-Infarct Dementia

Single-infarct and multi-infarct dementia are caused by one or more smaller strokes, respectively. When medium or large blood vessels become blocked with a clot, blood supply may be cut off for several minutes, leading to an infarct, or small area of dead tissue, within the brain. Similar to post-stroke dementia, the range of symptoms varies depending on the location and severity of damage.

Treating Vascular Dementia

Currently, the treatment of vascular dementia relies heavily on managing health conditions and controlling risk factors that contribute to vascular dementia. Implementing lifestyle changes, such as participating in regular physical activity, eating a healthy diet, engaging in mental and social activities, and avoiding alcohol and smoking may help slow the progression of vascular dementia.

While there are currently no approved treatments for vascular dementia, emerging research investigates how molecular mechanisms, such as oxidative stress, neuroinflammation, neuronal apoptosis, and synaptic plasticity, may provide future treatment options. 

Individuals with mixed cortical vascular dementia involving beta-amyloid plaques may benefit from new Alzheimer’s drugs, such as Aducanumab (Aduhelm).

Understanding Cognitive and Functional Changes in Vascular Dementia Patients

Regular assessments of both cognitive and functional abilities are critical for those diagnosed with vascular dementia to inform proper patient care and treatment. To do so, it is important to assess many neurocognitive domains and analyze highly granular data for the most detailed understanding of brain health.

Altoida is developing a Precision Neurology platform and highly sensitive app-based device to measure and assess neurocognitive function. Users engage in a 10-minute series of immersive augmented reality and motor activities designed to measure brain function across 13 neurocognitive domains through simulated Activities of Daily Living. While users complete digital activities on their smartphone or tablet, Altoida’s device collects and analyzes nearly 800 digital biomarkers associated with cognitive and functional impairment, providing patients a neurocognitive domain score report for a robust understanding of brain function.

To learn more about how Altoida’s Precision Neurology device may be used to identify cognitive and functional changes in patients with mixed cortical and subcortical vascular dementia, contact us today.

Contact Us

At Altoida, we use digital biomarkers to radically change the method of assessing brain health and cognitive diseases. After nearly two decades of research, we are developing a platform and device to measure and analyze cognitive biomarkers associated with cognitive impairment to evaluate perceptual and memory function.
Contact Us

Contact Us

80 M Street SE, Suite 100 Washington, DC 20003 USA 


Follow Us


By visiting our Website and/or using the Services in any manner, you acknowledge that you accept the practices and policies outlined in our Privacy Policy.
@ Altoida 2021